By March, leading members of the American Academy of Pediatrics were petitioning the FDA for a safety review of the drugs and, two weeks ago, FDA safety reviewers urged a ban on all over-the- counter cough and cold products for children younger than 6.
But with any kind of medicine--prescription or nonprescription--that is never the case," said Steier, who is a member of the FDA's respiratory drugs and devices panel.
Schumer said the products should have been targeted by the FDA.
